Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-104404
Filing Date
2026-09-01
Accepted
2026-09-01 21:39:55
Documents
1
Period of Report
2026-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2624615-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2624615-3_4seq1.xml 4 6496
  Complete submission text file 0001104659-26-104404.txt   8119
Mailing Address 42127 PLEASANT FOREST COURT ASHBURN VA 20148-7349
Business Address 42127 PLEASANT FOREST COURT ASHBURN VA 20148-7349 703 980 4182
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AZRIELI CENTER ROUND TOWER, 30TH FLOOR TEL AVIV L3 6701101
Business Address
Myers Michael (Reporting) CIK: 0001959547 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37846 | Film No.: 261352504